Source link : https://newshealth.biz/health-news/fda-expands-uzedy-indication-to-bipolar-i-disorder/

The FDA has approved risperidone once-monthly, extended-release injectable suspension for maintenance treatment of bipolar I disorder in adults. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-expands-uzedy-indication-bipolar-i-disorder-2025a1000rk1?src=rss Author : Publish date : 2025-10-13 16:48:00 Copyright for syndicated content belongs to the linked Source.

The post FDA Expands Uzedy Indication to Bipolar I Disorder first appeared on News Health.

—-

Author : News Health

Publish date : 2025-10-13 16:48:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678